Home / Insights / Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Read the full article: Global News Wire

12 January 2026

Posted in — Healthcare, News

Share
Share

You may also like

17 April 2026

OneVentures

Meet the women steering Australia’s high-tech future


17 April 2026

Growth Credit

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal


15 October 2025

Growth Equity

Accel-KKR Acquires Phocas Software


View All

Ventured. Gained.
decor